QUIA PHARMA
0,006
SEK
-6,67 %
QUIA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
-6,67%
-48,15%
-46,67%
-80%
-87,39%
-92,81%
-99,96%
-100%
-100%
QUIA PHARMA operates in medical technology. The company has developed a technological platform that is used to develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.
Læs mereMarkedsværdi
9,43 mio. SEK
Aktieomsætning
18,91 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Finanskalender
12.2
2025
Ekstraordinær generalforsamling '25
26.2
2025
Årsrapport '24
ViserAlle indholdstyper
QuiaPEG has submitted a formal application to Nasdaq for the reverse acquisition of Rosemonkey Ltd.
QuiaPEG och Net Zero Infrastucture take next step to a formal license agreement
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools